Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 140 | $52,883,940 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Feb 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 16 Feb 2023 | Sale | 100 | 252 | 25,200 | D |
16 Feb 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 16 Feb 2023 | Sale | 400 | 250.875 | 100,350 | D |
16 Feb 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 16 Feb 2023 | Sale | 1,216 | 249.648 | 303,572 | D |
16 Feb 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 16 Feb 2023 | Sale | 4,184 | 248.6666 | 1,040,421 | D |
02 Feb 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 02 Feb 2023 | Sale | 200 | 258.99 | 51,798 | D |
02 Feb 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 02 Feb 2023 | Sale | 1,400 | 255.4582 | 357,641 | D |
02 Feb 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 02 Feb 2023 | Sale | 4,400 | 254.1714 | 1,118,354 | D |
19 Jan 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 19 Jan 2023 | Sale | 300 | 259.9586 | 77,988 | D |
19 Jan 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 19 Jan 2023 | Sale | 4,500 | 259.021 | 1,165,594 | D |
19 Jan 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 19 Jan 2023 | Sale | 1,200 | 258.4176 | 310,101 | D |
05 Jan 2023 16:31 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 05 Jan 2023 | Sale | 704 | 274.759 | 193,430 | D |
05 Jan 2023 16:31 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 05 Jan 2023 | Sale | 3,096 | 274.1303 | 848,707 | D |
05 Jan 2023 16:31 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 05 Jan 2023 | Sale | 2,200 | 273.0805 | 600,777 | D |
16 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 15 Dec 2022 | Sale | 83 | 275.1978 | 22,841 | D |
16 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 15 Dec 2022 | Sale | 517 | 274.4315 | 141,881 | D |
16 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 15 Dec 2022 | Sale | 800 | 273.5337 | 218,827 | D |
16 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 15 Dec 2022 | Sale | 1,924 | 272.4799 | 524,251 | D |
16 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 15 Dec 2022 | Sale | 2,676 | 271.4353 | 726,361 | D |
16 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 15 Dec 2022 | Sale | 6,000 | 120.26 | 721,560 | D |
01 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 01 Dec 2022 | Sale | 526 | 279.49 | 147,012 | D |
01 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 01 Dec 2022 | Sale | 1,895 | 278.4563 | 527,675 | D |
01 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 01 Dec 2022 | Sale | 2,050 | 277.6831 | 569,250 | D |
01 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 01 Dec 2022 | Sale | 800 | 276.6056 | 221,284 | D |
01 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 01 Dec 2022 | Sale | 729 | 275.2463 | 200,655 | D |
17 Nov 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 17 Nov 2022 | Sale | 400 | 261.1762 | 104,470 | D |
17 Nov 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 17 Nov 2022 | Sale | 1,813 | 259.9665 | 471,319 | D |
17 Nov 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 17 Nov 2022 | Sale | 1,685 | 258.96 | 436,348 | D |
17 Nov 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 17 Nov 2022 | Sale | 2,102 | 257.925 | 542,158 | D |
04 Nov 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Nov 2022 | Sale | 2,200 | 258.5264 | 568,758 | D |
04 Nov 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Nov 2022 | Sale | 2,000 | 257.6285 | 515,257 | D |
04 Nov 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Nov 2022 | Sale | 600 | 255.8967 | 153,538 | D |
04 Nov 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 03 Nov 2022 | Sale | 1,200 | 254.1175 | 304,941 | D |
24 Oct 2022 16:33 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 20 Oct 2022 | Sale | 2,482 | 217.1968 | 539,082 | D |
24 Oct 2022 16:33 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 20 Oct 2022 | Sale | 2,618 | 216.6594 | 567,214 | D |
24 Oct 2022 16:33 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 20 Oct 2022 | Sale | 900 | 215.3128 | 193,782 | D |
06 Oct 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 06 Oct 2022 | Sale | 3,132 | 209.5565 | 656,331 | D |
06 Oct 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 06 Oct 2022 | Sale | 2,868 | 208.9365 | 599,230 | D |
26 Sep 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 22 Sep 2022 | Sale | 1,500 | 204.645 | 306,968 | D |
26 Sep 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 22 Sep 2022 | Sale | 2,300 | 203.3303 | 467,660 | D |
26 Sep 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 22 Sep 2022 | Sale | 2,200 | 202.4638 | 445,420 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)